RTW Biotech Opportunities
British investment trust
From Wikipedia, the free encyclopedia
RTW Biotech Opportunities is a large British investment trust focused on investments in the biotechnology industry. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[1]
| |
| Industry | Investment trust |
|---|---|
| Founded | 2019 |
| Headquarters | London, United Kingdom |
| Website | www |
History
Established in 2019, the company invests in companies at all stages of development from the early stages of testing to full production of pharmaceuticals.[2] Work by the administration of President Donald Trump to reach agreement with pharmaceutical companies over drug prices and tariffs, together with renewed mergers & acquisitions activity in the sector, led to renewed interest in the sector, and the company in particular, in the second half of 2025.[3][4] The company is managed by RTW Investments and the chairman is William Simpson.[5]